

Travelers vs Manulife
Major US property and casualty insurer with scale vs Canadian insurer and wealth manager serving US and Asia. Which is the better buy for your portfolio in September 2026? Plain-English answer below.
Travelers is a US property-casualty insurance titan with pricing power across personal and commercial lines, consistently posting combined ratios that outperform peers through disciplined underwriting, while Manulife operates as a diversified life insurer and wealth manager across North America and Asia with significant exposure to Hong Kong and mainland Chinese policyholders. Both are large-cap insurance companies navigating rising catastrophe losses and interest rate sensitivity, but their geographic mix and product mix tell very different stories. The Travelers vs Manulife comparison reveals how domestic P&C pricing cycles compare to long-duration life insurance reserves and Asia-driven premium growth.
Travelers is a US property-casualty insurance titan with pricing power across personal and commercial lines, consistently posting combined ratios that outperform peers through disciplined underwriting...
Why It’s Moving

Travelers faces mild downside pressure as analysts flag valuation after a strong earnings run
- Analysts turned more cautious after Travelers’ strong second-quarter results, arguing the stock has already priced in much of the underwriting strength and capital-return story.
- A recent dividend declaration and steady payout reinforce cash-generation visibility, but they have not been enough to offset valuation concerns around limited near-term upside.
- Insider selling by a senior risk executive added to the cautious tone, with investors treating it as a small but notable signal after the stock’s strong run.

MFC steadies after strong earnings and capital moves, even as analysts warn of deep downside
- Manulife’s recent Q2 results showed stronger-than-expected core earnings, which helped steady sentiment and kept the stock near its recent highs.
- The company also priced US$750 million of subordinated notes, a capital-raising move that strengthens its balance sheet but can make investors focus more on financing costs and future returns.
- Analyst commentary remains mixed around the stock, with some firms turning less negative while broader caution persists about valuation and the gap between current prices and bearish downside estimates.

Travelers faces mild downside pressure as analysts flag valuation after a strong earnings run
- Analysts turned more cautious after Travelers’ strong second-quarter results, arguing the stock has already priced in much of the underwriting strength and capital-return story.
- A recent dividend declaration and steady payout reinforce cash-generation visibility, but they have not been enough to offset valuation concerns around limited near-term upside.
- Insider selling by a senior risk executive added to the cautious tone, with investors treating it as a small but notable signal after the stock’s strong run.

MFC steadies after strong earnings and capital moves, even as analysts warn of deep downside
- Manulife’s recent Q2 results showed stronger-than-expected core earnings, which helped steady sentiment and kept the stock near its recent highs.
- The company also priced US$750 million of subordinated notes, a capital-raising move that strengthens its balance sheet but can make investors focus more on financing costs and future returns.
- Analyst commentary remains mixed around the stock, with some firms turning less negative while broader caution persists about valuation and the gap between current prices and bearish downside estimates.
Investment Analysis

Travelers
TRV
Pros
- Reported a 30% increase in net income to $3.79 billion for the first nine months of 2025, indicating strong profitability growth.
- Achieved a 22.6% core return on equity in Q3 2025, supported by strong underwriting results and higher net investment income.
- Maintains a solid financial position with a debt/equity ratio of 29.3% and an $8.034 billion debt level amid $40.583 billion total capital.
Considerations
- Net realized investment gains dropped in Q3 2025 compared to the prior year quarter, from $42 million to $21 million after tax, suggesting some volatility in investment income.
- Growth largely reliant on favorable underwriting performance and lower catastrophe losses, which can be unpredictable.
- Recent market valuation gains and digital strategy enhancements raise questions about potential overvaluation and future risk profiles.

Manulife
MFC
Pros
- Manulife has a strong global presence with diversified life insurance and wealth management products fostering stable revenue streams.
- Reports consistent premium growth and expanding asset management offerings, benefiting from demographic trends and retirement planning demand.
- Solid capital adequacy and liquidity positions support its ability to invest in growth initiatives and manage regulatory requirements.
Considerations
- Exposure to interest rate risk and market volatility can impact investment returns and liabilities valuation, affecting profitability.
- Competitive pressures in core insurance markets may compress margins and slow premium growth rates.
- Regulatory changes in multiple jurisdictions impose complexity and potential compliance costs, challenging operational efficiency.
Travelers (TRV) Next Earnings Date
The next earnings date for TRV is expected on October 15, 2026. That report will cover third-quarter 2026 results. The date is based on the company’s usual mid-October reporting pattern if it is not formally confirmed earlier.
Manulife (MFC) Next Earnings Date
The next expected earnings date for MFC is November 4, 2026, based on the company’s typical reporting pattern. This release would cover Q3 2026 results. If the date shifts, the earnings call has generally followed shortly afterward.
Travelers (TRV) Next Earnings Date
The next earnings date for TRV is expected on October 15, 2026. That report will cover third-quarter 2026 results. The date is based on the company’s usual mid-October reporting pattern if it is not formally confirmed earlier.
Manulife (MFC) Next Earnings Date
The next expected earnings date for MFC is November 4, 2026, based on the company’s typical reporting pattern. This release would cover Q3 2026 results. If the date shifts, the earnings call has generally followed shortly afterward.
Buy TRV or MFC in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.


